We are MMCORC, a #NCORP of 22 community hospitals and oncology clinics with over 250 providers offering #ClinicalTrials to people in their own communities.
AFT study in @JCOOA_ASCO shows simple weekly digital symptom check-in improves quality of life and reduces emergency room visits for patients with advanced cancer by bridging
communication gaps. News release - https://t.co/GXQHIBXclp. Study: https://t.co/K64IvPBieF
“Why I Said No”: Trial-Eligible Patient Perspectives on Declining Breast Cancer Clinical Trial Participation | JCO Oncology Practice https://t.co/xRhzKDmPJ9
November is Gastric Cancer Awareness Month. The Alliance has two active trials aimed at improving treatments in this population – PAGODA A232402CD and A022102. Learn more about these trials at https://t.co/gTGiXoLNpn and https://t.co/adADpZ9ENz.
This @Movember the Alliance org is highlighting 8 ongoing clinical trials focused on advancing detection, treatment, and survivorship for men’s cancers, including prostate cancer. Learn more about how clinical research is shaping care: https://t.co/OwH3x9oo2s #PCSM#movember
Learn about two pathways for genetic testing: myGenetics and clinical genetic testing
@_HealthPartners
- Also opportunities to participate in existing studies about hereditary cancer syndromes
@MMCORC
Meeting Registration - Meeting Registration - https://t.co/LXyeKBOud6
New lung cancer trial open @MMCORC 🧪A082402 is studying if targeted post op radiation (I² PORT) can reduce recurrence in high risk #NSCLC patients after surgery while limiting side effects. Learn more https://t.co/xA4x6lolvd. #LungCancer#ClinicalTrials#RadiationTherapy
Patients with newly diagnosed #MultipleMyeloma may be eligible to participate in #ClinicalTrial at https://t.co/bhOX4HK0xf EAA181/EQUATE. Learn more here: https://t.co/Q8T7rLLmGy
ICYMI – the October issue of the NRG Oncology newsletter is available. This issue highlights plenty of content for #BreastCancerAwarenessMonth. Check it out here: https://t.co/jUuwTtX3DH
@MMCORC at AICAF Powwow for Hope along with our consortium members @HennepinHC@AllinaHealth and @mnoncology. It was a community healing event that celebrated Native cancer survivors and strengthened connections towards eliminating the cancer burdens of Indigenous people.
Sharing with you @NRGonc communication that takes community members behind the scenes of research process and results > including SUMMARY OF RESULTS FOR PATIENTS section.
NRG Oncology is currently accepting applications for travel awards to #NRG2027 in Las Vegas! Application window closes November 9th. More information can be found at https://t.co/HvRIdKyPN3
792 locations, including @MMCORC! A022102 is studying mFOLFIRINOX vs mFOLFOX with or without immunotherapy drug nivolumab for metastatic HER2 negative esophageal, gastroesophageal junction and gastric cancer. More: https://t.co/LRgXpQGPnc #ColorectalCancer#clinicaltrials
MMCORC @AllinaHealth Research Day 2026 - sharing a day of innovation and celebration! Together we provide over 100 clinical trial options to the community and have a research team ready to help.
October is #BreastCancerAwarenessMonth. Clinical trial research plays a critical role in improving cancer care. We remain committed to advancing clinical trials that help answer important ?s and brings new knowledge to patients & the cancer community. https://t.co/U2MQoBqG9e
Protocol Activation @MMCORC! NRG-CC017: A randomized phase III study comparing temporally-modulated pulsed radiation therapy (TMPRT) versus standard radiation therapy with temozolomide for adults with newly diagnosed MGMT-unmethylated glioblastoma https://t.co/YicXRZNzHm
Now Available @MMCORC > A012303 (ShortStop-HER2), a study testing if less treatment after surgery is an option for people with early-stage HER2+ #breastcancer who had no cancer left after chemo + HER2 therapy. https://t.co/0Cly621ecB